Sinopharm Tech Holdings Ltd. has announced several key management changes. An executive director, group chief financial officer, and compliance officer have resigned. Additionally, the company has appointed a new company secretary and authorized representative. The board now includes executive directors Mr. Chiu Sin Nang Kenny and Ms. Kwok Shuk Yi, non-executive director Dr. Cheng Yanjie, and independent non-executive directors Mr. Lau Fai Lawrence, Mr. Hsu Dong An, and Mr. Heung Pik Lun.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。